Patents Assigned to Bayer
  • Publication number: 20240242350
    Abstract: The present invention relates to the technical field of producing artificial contrast-enhanced radiological images by way of machine learning methods.
    Type: Application
    Filed: May 25, 2022
    Publication date: July 18, 2024
    Applicant: Bayer Aktiengesellschaft
    Inventor: Matthias LENGA
  • Publication number: 20240225448
    Abstract: The invention relates to the technical field of characterising lesions in the liver using dynamic contrast-enhanced magnetic resonance tomography.
    Type: Application
    Filed: April 28, 2022
    Publication date: July 11, 2024
    Applicant: Bayer Aktiengesellschaft
    Inventors: Gunnar SCHUETZ, Gesine KNOBLOCH
  • Patent number: 12029673
    Abstract: A handcuff for the treatment of the carpal tunnel syndrome of a hand, the handcuff comprising a base body including a dorsal section and a palmar section. The dorsal section is adapted to exert a pressure on the dorsal side of the hand at at least one location, the palmar section is arranged to exert a pressure on the palmar side of the hand on both sides of the carpal tunnel respectively at at least one location on both sides of the carpal tunnel, and the dorsal section and the palmar section are arranged to widen the carpal tunnel of the hand by the exertion of pressure. In embodiments, the base body has, between the dorsal section and the palmar section, two substantially opposite open slots, between the dorsal section and the palmar section, and the slots are adapted to receive the thumb of the left or the right hand.
    Type: Grant
    Filed: September 20, 2021
    Date of Patent: July 9, 2024
    Assignee: BAYER FEINWERK GMBH & CO. KG
    Inventor: Uwe Heiter
  • Patent number: 12023475
    Abstract: A fluid injection system and a fluid verification system for determining the operating status of the fluid injection system, for example by confirming that a fluid reservoir, containing a fluid for injection, is fully filled with fluid and has free space (i.e., air) near the distal end thereof when the syringe is provided in an upright position nor contains air bubbles. Imaging processing techniques, methods, and systems are also provided to determine various injection parameters and to verify the type and certain properties of fluid that is present within the fluid reservoir.
    Type: Grant
    Filed: March 25, 2022
    Date of Patent: July 2, 2024
    Assignee: BAYER HEALTHCARE LLC
    Inventors: Kevin Cowan, Michael Spohn, Michael McDermott
  • Patent number: 12023319
    Abstract: The present invention relates to carboxylic acid aromatic amides compounds of general formula (I) as described and defined herein, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease as a sole agent or in combination with other active ingredients.
    Type: Grant
    Filed: September 17, 2021
    Date of Patent: July 2, 2024
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Stefan Bäurle, Adam James Davenport, Christopher Stimson, Jens Nagel, Nicole Schmidt, Andrea Rotgeri, Ina Gröticke, Alexandra Rausch, Juergen Klar, Thomas Dyrks
  • Patent number: 12023464
    Abstract: A cassette for holding fluid path components for a fluid injector may include a body defining at least one feature for holding at least one fluid path component for the fluid injector; and a connecting member for removably connecting the body of the cassette to the fluid injector, the connecting member operatively connected to the body, wherein the connecting member comprises at least one pivotable connecting feature protruding from the body, and wherein each of the at least one pivotable connecting feature is configured for removably connecting to a corresponding connecting feature receiver on the fluid injector such that the body is pivotally movable relative to the fluid injector between a first, unlatched position and a second, latched position in which the at least one fluid path component on the body of the cassette is positioned for operative connection to a corresponding feature of the fluid injector.
    Type: Grant
    Filed: November 30, 2021
    Date of Patent: July 2, 2024
    Assignee: BAYER HEALTHCARE LLC
    Inventors: Andrew Naples, Kevin Cowan, Michael Spohn, John Haury, Patrick Campbell, James Dedig, Randy Lee, John Caswell, Katherine MacNamee, James Tirone
  • Publication number: 20240212811
    Abstract: A method for training a machine learning model that is able to establish links between data of different modalities by creating a joint representation. In particular, application of the method to medical data including electronic medical records and medical images and/or other medical data. The trained machine learning model can among others fulfil tasks such as autocompletion of incomplete data, detection of uncertain and/or spurious data, generation of probable data and other tasks.
    Type: Application
    Filed: April 20, 2022
    Publication date: June 27, 2024
    Applicant: Bayer Aktiengesellschaft
    Inventors: Steffen VOGLER, Johannes HOEHNE, Matthias LENGA
  • Patent number: 12016932
    Abstract: Provided herein, in some embodiments, are materials and methods for treating hemophilia A in a subject ex vivo or in vivo. Also provided herein, in some embodiments, are materials and methods for knocking in a coding sequence encoding a synthetic FVIII having a B domain substitute into a genome.
    Type: Grant
    Filed: November 15, 2022
    Date of Patent: June 25, 2024
    Assignees: CRISPR THERAPEUTICS AG, BAYER HEALTHCARE LLC
    Inventor: Alan Richard Brooks
  • Patent number: 12016912
    Abstract: The present invention relates to a composition comprising a) recombinant exosporium-producing Bacillus cells that express a fusion protein comprising: (i) at least one plant growth stimulating protein or peptide and (ii) a targeting sequence that localizes the fusion protein to the exosporium of the Bacillus cells; and b) at least one particular insecticide disclosed herein in a synergistically effective amount. Furthermore, the present invention relates to the use of this composition as well as a method for enhancing plant growth, promoting plant health, and/or reducing overall damage of plants and plant parts.
    Type: Grant
    Filed: June 24, 2021
    Date of Patent: June 25, 2024
    Assignees: Bayer CropScience LP, Spogen Biotech Inc.
    Inventors: Damian Curtis, Brian Thompson
  • Publication number: 20240197626
    Abstract: The present disclosure relates to chewable gel products containing a gel carrier and an active pharmaceutical ingredient (API), where the chewable gel product has an acceptable taste.
    Type: Application
    Filed: December 21, 2023
    Publication date: June 20, 2024
    Applicant: Bayer Healthcare LLC
    Inventors: Rachan SIRIHORACHAI, Reginald D Bradley, Paul D. Rosar, Anthony Ekpe
  • Patent number: 12011568
    Abstract: A high crack pressure valve is described. The high crack pressure valve includes an inlet adapted to receive a medical fluid pressurized by a pump; an outlet in fluid communication with a fluid path element, wherein the fluid path element is in fluid communication with downstream system components of a fluid delivery system; and a moveable element having a crack pressure threshold. The moveable element has a first closed position and a second open position and is configured to move from the first closed position to the second open position when a fluid pressure at the inlet is greater than or equal to the crack pressure threshold. The pressure of fluid at the outlet of the high crack pressure valve has little or no effect on movement of the moveable element from the first closed position to the second open position. Fluid injector systems and fluid path elements which include the high crack pressure valve are also described.
    Type: Grant
    Filed: July 12, 2021
    Date of Patent: June 18, 2024
    Assignee: BAYER HEALTHCARE LLC
    Inventors: Arthur Uber, III, Mark Trocki
  • Publication number: 20240193738
    Abstract: A method of training a prediction tool to generate at least one synthetic full-contrast image from zero-contrast and low-contrast images of a subject may involve receiving a training set a set of images of a set of subjects, the images of each subject comprising a full-contrast image, a low-contrast image, a first zero-contrast image acquired prior to the acquisition of the full-contrast image, and a second zero-contrast image acquired prior to the acquisition of the low-contrast image. An artificial neural network may be trained with the training set by applying the first and second zero-contrast images from the set of images and the low-contrast images from the set of images as input to the artificial neural network and using a cost function to compare the output of the artificial neural network with the full-contrast images from the set of images to train parameters of the artificial neural network using backpropagation.
    Type: Application
    Filed: April 13, 2022
    Publication date: June 13, 2024
    Applicant: Bayer Aktiengesellschaft
    Inventors: Veronica CORONA, Marvin PURTORAB, Sara LORIO, Thiago RAMOS DOS SANTOS
  • Patent number: 12006303
    Abstract: The present application relates to novel substituted indazoles, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially for treatment and/or prophylaxis of endometriosis and endometriosis-associated pain and other endometriosis-associated symptoms such as dysmenorrhoea, dyspareunia, dysuria and dyschezia, of lymphoma, rheumatoid arthritis, spondyloarthritis (especially psoriatic spondyloarthritis and Bekhterev's disease), lupus erythematosus, multiple sclerosis, macular degeneration, COPD, gout, fatty liver disorders, insulin resistance, neoplastic disorders and psoriasis.
    Type: Grant
    Filed: July 20, 2022
    Date of Patent: June 11, 2024
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Ulrich Bothe, Holger Siebeneicher, Nicole Schmidt, Reinhard Nubbemeyer, Ulf Bömer, Judith Günther, Holger Steuber, Martin Lange, Christian Stegmann, Andreas Sutter, Alexandra Rausch, Christian Friedrich, Peter Hauff
  • Patent number: 12006327
    Abstract: The present invention relates to a novel process for preparing substituted cyclohexane amino acid esters and spiroketal-substituted cyclic keto-enols, and to novel intermediates or starting compounds that are passed through or used in the process according to the invention.
    Type: Grant
    Filed: April 3, 2019
    Date of Patent: June 11, 2024
    Assignee: BAYER AKTIENGESELLSCHAFT
    Inventors: Thomas Himmler, Peter Bruechner, Werner Lindner, Julia Johanna Hahn, Wahed Ahmed Moradi, Reiner Fischer, Michael Dockner
  • Patent number: 12005107
    Abstract: The present invention relates to a composition comprising a) recombinant exosporium-producing Bacillus cells that express a fusion protein comprising: (i) at least one plant growth stimulating protein or peptide and (ii) a targeting sequence that localizes the fusion protein to the exosporium of the Bacillus cells; and b) at least one particular fungicide disclosed herein in a synergistically effective amount. Furthermore, the present invention relates to the use of this composition as well as a method for enhancing plant growth, promoting plant health, and/or reducing overall damage of plants and plant parts.
    Type: Grant
    Filed: June 24, 2021
    Date of Patent: June 11, 2024
    Assignee: Bayer CropScience LP
    Inventors: Damian Curtis, Brian Thompson
  • Patent number: 12006304
    Abstract: The present application relates to novel substituted indazoles, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially for treatment and/or prophylaxis of endometriosis and endometriosis-associated pain and other endometriosis-associated symptoms such as dysmenorrhoea, dyspareunia, dysuria and dyschezia, of lymphoma, rheumatoid arthritis, spondyloarthritis (especially psoriatic spondyloarthritis and Bekhterev's disease), lupus erythematosus, multiple sclerosis, macular degeneration, COPD, gout, fatty liver disorders, insulin resistance, neoplastic disorders and psoriasis.
    Type: Grant
    Filed: July 20, 2022
    Date of Patent: June 11, 2024
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Ulrich Bothe, Holger Siebeneicher, Nicole Schmidt, Reinhard Nubbemeyer, Ulf Bömer, Judith Günther, Holger Steuber, Martin Lange, Christian Stegmann, Andreas Sutter, Alexandra Rausch, Christian Friedrich, Peter Hauff
  • Publication number: 20240182431
    Abstract: The present invention relates to a new class of compounds of general formula (I), the Gd3+ chelate complexes thereof, to methods of preparing said compounds, and to the use of said compounds as MRI contrast agents.
    Type: Application
    Filed: March 14, 2022
    Publication date: June 6, 2024
    Applicants: Bayer Aktiengesellschaft, Bayer Aktiengesellschaft
    Inventors: Thomas BRUMBY, Jessica LOHRKE, Simon Anthony HERBERT, Olaf PANKNIN, Thomas FRENZEL, Claudia GREEN, Gregor JOST, Hubertus PIETSCH, Markus BERGER, Sven WITTROCK
  • Publication number: 20240185577
    Abstract: The present invention relates to the technical field of machine learning. Subject matter of the present invention is a novel approach for training a neural network and the use of this approach for the processing of (medical) images.
    Type: Application
    Filed: March 24, 2022
    Publication date: June 6, 2024
    Applicant: Bayer Aktiengesellschaft
    Inventors: Matthias LENGA, Marvin PURTORAB, Thiago RAMOS DOS SANTOS, Jens HOOGE, Veronica CORONA
  • Publication number: 20240182452
    Abstract: The present invention provides dihydropyridazinone compounds of general formula (I) in which R1, R2 and R3 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative diseases, as a sole agent or in combination with other active ingredients.
    Type: Application
    Filed: December 28, 2023
    Publication date: June 6, 2024
    Applicants: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft, The Broad Institute, Inc., Dana-Farber Cancer Institute, Inc.
    Inventors: Manuel ELLERMANN, Stefan Nikolaus GRADL, Charlotte Christine KOPITZ, Martin LANGE, Adrian TERSTEEGEN, Philip LIENAU, Detlev SÜLZLE, Timothy LEWIS, Heidi GREULICH, Xiaoyun WU, Matthew MEYERSON
  • Patent number: D1031029
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: June 11, 2024
    Assignee: Bayer Healthcare LLC
    Inventors: Michael Swantner, Richard Seman, Kevin Cowan, Arthur Uber, III